RGNX - REGENXBIO Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue218,50510,3934,5897,588
Cost of Revenue9,64058,93346,44118,782
Gross Profit208,865-48,540-41,852-11,194
Operating Expenses
Research Development83,87383,87383,87383,873
Selling General and Administrative36,85027,22923,59011,912
Non Recurring----
Others42116-10231
Total Operating Expenses130,40586,27869,92930,725
Operating Income or Loss88,100-75,885-65,340-23,137
Income from Continuing Operations
Total Other Income/Expenses Net16,0162,7161,938326
Earnings Before Interest and Taxes88,100-75,885-65,340-23,137
Interest Expense----20
Income Before Tax104,116-73,169-63,402-22,811
Income Tax Expense4,179--435-
Minority Interest----
Net Income From Continuing Ops99,937-73,169-62,967-22,811
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income99,937-73,169-62,967-22,811
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares99,937-73,169-62,967-23,799